logo

For the Inventor, By the Inventor

Walkersville, MD, United States of America

John H Cardellina, Ii

This inventor holds 12 USPTO granted patents. Top assignees: The United States of America as Represented by the Department of Health, The United States of America as Represented by the Secretary of, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1994-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John H Cardellina, Ii. Retrieved from https://idiyas.com/inventor/john-h-cardellina-ii

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 12

% Patents Active = 100.0

Average Co-Inventor Count = 7.7

ph-index = 3

Forward Citations = 34(Granted Patents)


Company Filing History:

goldMedal6 out of 1,217 
 
The United States of America as Represented by the Department of Health
 patents
silverMedal2 out of 2,202 
 
The United States of America as Represented by the Secretary of
 patents
bronzeMedal2 out of 3,699 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
4. 2 out of 2,437 
 
University of Illinois
 patents
5. 1 out of 481 
 
Brigham Young University
 patents
6. 1 out of 13 
 
The United States of America as Represented by the Secretary, Department
 patents
7. 1 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 1994-2004

Loading Chart...
12 patents (USPTO):Explore Patents
1. 6774141 - Calanolide and related antiviral compounds, compositions, and uses thereof (2004-08-10),
2. 6673830 - Calanolide and related antiviral compounds, compositions, and uses thereof (2004-01-06),
3. 6353019 - Macrocyclic lactones, compositions, and methods of use (2002-03-05),
4. 5859049 - Calanolide and related antiviral compounds, compositions, and uses (1999-01-12),
5. 5783598 - Antiretroviral naphthoquinone compounds compositions and uses thereof (1998-07-21),
6. 5672607 - Antiviral naphthoquinone compounds, compositions and uses thereof (1997-09-30),
7. 5654432 - Process of preparing michellamine compounds (1997-08-05),
8. 5599839 - Antiviral composition (1997-02-04),
9. 5591770 - Calanolide and related antiretroviral compounds, compositions, and uses (1997-01-07),
10. 5455251 - Michellamine antiviral agents, compositions, and treatment methods (1995-10-03),
11. 5409938 - Antimalarial korupensamines and pharmaceutical compositions and medical (1995-04-25),
12. 5283383 - Antitumor compound, compositions and method of use (1994-02-01),

Title: John H Cardellina II: Innovator in Antiviral Compounds

Introduction

John H Cardellina II is a notable inventor based in Walkersville, MD (US). He has made significant contributions to the field of antiviral compounds, holding a total of 12 patents. His work focuses on developing novel compounds that can combat viral infections, particularly those caused by retroviruses.

Latest Patents

One of Cardellina's latest patents is titled "Calanolide and related antiviral compounds, compositions, and uses thereof." This invention provides novel antiviral compounds known as calanolides, which can be isolated from plants of the genus Calophyllum. These compounds and their derivatives may be utilized alone or in combination with other antiviral agents in pharmaceutical compositions. The primary aim is to inhibit the growth or replication of viruses, specifically targeting human immunodeficiency viruses, HIV-1 and HIV-2.

Career Highlights

Throughout his career, Cardellina has worked with esteemed organizations, including the United States of America as represented by the Department of Health. His research has been pivotal in advancing antiviral therapies and improving public health outcomes.

Collaborations

Cardellina has collaborated with notable professionals in his field, including Michael R Boyd and James Brislin McMahon. These partnerships have contributed to the success of his research and the development of innovative antiviral solutions.

Conclusion

John H Cardellina II stands out as a significant figure in the realm of antiviral research. His inventions and collaborations have the potential to make a lasting impact on the treatment of viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…